Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Szalat

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Application of Clinical Genetics|May 6, 2021
Genetic Predictors of Mortality in Patients with Multiple MyelomaHamza Hassan, Raphael Szalat
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Next-Generation Sequencing Informing Therapeutic Decisions and Personalized ApproachesRaphael Szalat, Nikhil C Munshi
Haematologica|February 8, 2024
Role of minimal residual disease assessment in multiple myelomaRaphael Szalat, Kenneth Anderson, Nikhil Munshi
Blood|May 17, 2023
Single-cell profiling in multiple myeloma: insights, problems, and promisesMehmet Kemal Samur, Raphael Szalat, Nikhil C Munshi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Gene Expression Profiles in Myeloma: Ready for the Real World?Raphael Szalat, Herve Avet-Loiseau, Nikhil C Munshi
Haematologica|March 20, 2025
Teclistamab therapy for refractory type 1 cryoglobulinemiaJustin Battaglini, Joel Henderson, Vaishali Sanchorawala, et al.
International Journal of Epidemiology|November 9, 2025
Neighborhood disadvantage and multiple myeloma incidence in the Black Women's Health StudyEtienne X Holder, Raphael Szalat, Julie R Palmer, et al.
American Journal of Hematology|September 22, 2025
Bleeding Patterns and Clinical Outcomes in Patients With Systemic AL Amyloidosis-Related Acquired Factor X DeficiencyOkan Cetin, Andrew Staron, Patric Teodorescu, et al.
British Journal of Cancer|January 11, 2024
Body size and risk of multiple myeloma in the Black Women's Health StudyYachana Kataria, Bala Niharika Pillalamarri, Gary Zirpoli, et al.
Autoimmunity Reviews|May 12, 2010
Anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: Clinical and immunological features: A propos of 40 new cases and review of the literatureRaphael Szalat, Pascale Ghillani-Dalbin, Moez Jallouli, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Application of Clinical Genetics|May 6, 2021
Genetic Predictors of Mortality in Patients with Multiple MyelomaHamza Hassan, Raphael Szalat
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Next-Generation Sequencing Informing Therapeutic Decisions and Personalized ApproachesRaphael Szalat, Nikhil C Munshi
Haematologica|February 8, 2024
Role of minimal residual disease assessment in multiple myelomaRaphael Szalat, Kenneth Anderson, Nikhil Munshi
Blood|May 17, 2023
Single-cell profiling in multiple myeloma: insights, problems, and promisesMehmet Kemal Samur, Raphael Szalat, Nikhil C Munshi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Gene Expression Profiles in Myeloma: Ready for the Real World?Raphael Szalat, Herve Avet-Loiseau, Nikhil C Munshi
Haematologica|March 20, 2025
Teclistamab therapy for refractory type 1 cryoglobulinemiaJustin Battaglini, Joel Henderson, Vaishali Sanchorawala, et al.
International Journal of Epidemiology|November 9, 2025
Neighborhood disadvantage and multiple myeloma incidence in the Black Women's Health StudyEtienne X Holder, Raphael Szalat, Julie R Palmer, et al.
American Journal of Hematology|September 22, 2025
Bleeding Patterns and Clinical Outcomes in Patients With Systemic AL Amyloidosis-Related Acquired Factor X DeficiencyOkan Cetin, Andrew Staron, Patric Teodorescu, et al.
British Journal of Cancer|January 11, 2024
Body size and risk of multiple myeloma in the Black Women's Health StudyYachana Kataria, Bala Niharika Pillalamarri, Gary Zirpoli, et al.
Autoimmunity Reviews|May 12, 2010
Anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: Clinical and immunological features: A propos of 40 new cases and review of the literatureRaphael Szalat, Pascale Ghillani-Dalbin, Moez Jallouli, et al.
Pageof 4